Loading...
Loading...

by Sun Pharmaceutical Ind, Ltd· 15s
SKU: 1182258
You save ₹99 on this order
Inclusive of all taxes
TOFASHINE XR 11MG TABLET contains Tofacitinib, a disease-modifying
anti-rheumatic drug (DMARD) belonging to the Janus kinase (JAK) inhibitors
class. It is used to manage moderate to severe inflammatory conditions including
rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and
ulcerative colitis.
TOFASHINE XR 11MG TABLET inhibits Janus kinase enzymes (JAK 1 and JAK 3),
blocking the signaling pathways that lead to inflammation and immune system
overactivation. This results in reduced pain, swelling, and tissue damage in
autoimmune conditions.
Take TOFASHINE XR 11MG TABLET exactly as prescribed by your doctor, usually once
or twice daily. Swallow the tablet whole with water, with or without food. Do
not crush or chew the tablet. Consistent dosing at the same time each day helps
maintain symptom control.
Inform your doctor if you have infections, liver or kidney disease, or a history
of tuberculosis before starting TOFASHINE XR 11MG TABLET. Pregnant or
breastfeeding women should consult their healthcare provider before use.
Avoid live vaccines without medical approval while taking this medication.
Regular monitoring of blood counts and liver function is necessary during
treatment. The common side effects are headache, dizziness, respiratory
infections, increased cholesterol levels, nausea, diarrhea, abdominal pain and
increased risk of serious infections.
TOFASHINE XR 11MG TABLET inhibits Janus kinase enzymes (JAK 1 and JAK 3),
blocking the signaling pathways that lead to inflammation and immune system
overactivation. This results in reduced pain, swelling, and tissue damage in
autoimmune conditions.
TOFASHINE XR 11MG TABLET can be taken with or without food according to medical
sources. It is recommended to take the tablet at the same time each day to
maintain consistent drug levels and o
with food may help reduce potential stomach upset, but it is not mandatory.
It is not safe to crush, chew, break, or split TOFASHINE XR 11MG TABLET. The
tablet should be swallowed whole with water to ensure proper absor
effectiveness.
If you miss a dose, take it as soon as you remember unless it is almost time for
your next scheduled dose. In that case, skip the missed dose and continue with
your regular dosing schedule. Do not take a double dose to make up for the
missed one, as this could increase the risk of side effects.
If you or anyone else accidentally take too much of TOFASHINE XR 11MG TABLET,
consult your doctor immediately or visit the nearby hospital.
!### Pregnancy
ContraindicatedTOFASHINE XR 11MG TABLET is not recommended for use in pregnant women or women
planning to have a baby. If you are a woman of childbearing age, you should use
effective birth control during management and for at least 4 weeks after the
last dose.
!### Breastfeeding
ContraindicatedTOFASHINE XR 11MG TABLET is not recommended for use in breastfeeding women.
!### Driving and Using Machines
Use with CautionTOFASHINE XR 11MG TABLET does not affect your ability to drive or use machines.
!### Kidney
Use with CautionTOFASHINE XR 11MG TABLET should be taken with caution in patients with kidney
disease. The dose will be adjusted by your doctor.
!### Liver
Consult your doctorTOFASHINE XR 11MG TABLET is not recommended in patients with severe liver
problems such as cirrhosis (scarring of the liver). It should be used with
caution in patients having other liver diseases such as hepatitis B or hepatitis
C. Dose will be adjusted by your doctor.
!### Allergy
ContraindicatedDo not take TOFASHINE XR 11MG TABLET if you are allergic to Tofacitinib or any
other ingredients of this medicine.
!### Lungs
Consult your doctorTOFASHINE XR 11MG TABLET is not recommended for use in active tuberculosis. It
should be taken with caution in patients with chronic lung disease or a history
of tuberculosis.
!### Heart Disease
Use with CautionTOFASHINE XR 11MG TABLET should be taken with caution in patients with heart
diseases such as heart attack and high blood pressure.
!### Use In Pediatrics
Consult your doctorThe safety and effectiveness of TOFASHINE XR 11MG TABLET in children below 2
years of age have not been established yet.
!### Use In Geriatrics
Use with CautionTOFASHINE XR 11MG TABLET should be used with caution in patients above the age
of 65 years of age as they may be at increased risk of infections, heart attack
and some types of cancer.
Before taking TOFASHINE XR 11MG TABLET, inform your doctor if you have,
TOFASHINE XR 11MG TABLET is not recommended for use if you have:
Maintain a nutritious, well-balanced diet rich in fruits, vegetables, lean
proteins, and whole grains to support overall health and immune function. Stay
well-hydrated to assist medication metabolism and reduce potential
gastrointestinal side effects.
Engage in low-impact exercises such as walking, swimming, or yoga to improve
joint flexibility, muscle strength, and cardiovascular health without
overstressing inflamed joints.
Because TOFASHINE XR 11MG TABLET suppresses the immune system, practice good
hygiene, avoid close contact with sick individuals, get recommended
vaccinations, and promptly report signs of infection to your healthcare
provider.
Smoking may worsen inflammatory conditions and impair healing, while excessive
alcohol can increase liver stress and gastrointestinal risks. Aim to quit
smoking and limit alcohol intake under medical guidance.
Incorporate relaxation techniques like meditation, deep breathing exercises, or
counselling to reduce stress, which can exacerbate autoimmune symptoms.
Adhere strictly to scheduled blood tests and healthcare appointments to monitor
treatment efficacy and side effects, enabling timely adjustments.
Tuberculosis and Infections:
Patients with active tuberculosis or a history of latent TB should be screened
and managed appropriately before starting TOFASHINE XR 11MG TABLET. The drug
suppresses immune response, increasing susce
vigilance is essential.
Hepatitis
Use caution in patients with a history of hepatitis B or C. Liver function
should be monitored regularly, as TOFASHINE XR 11MG TABLET may affect liver
enzymes and exacerbate underlying liver conditions.
Grapefruit products and St. John’s Wort can affect metabolism and should be
avoided.
| Drug | Tofacitinib |
| Pharmacological Category | Janus Kinase Inhibitors |
| Therapeutic Indication | Inflammatory diseases |
| Dosage Forms | Tablet |
Briefly contrast TOFASHINE XR 11MG TABLET with older DMARDs or biologics
regarding efficacy, side effects, administration ease, or monitoring needs.
TOFASHINE XR 11MG TABLET differs from older traditional DMARDs and biologic
therapies in several important ways that contribute to its unique value:
Tofacitinib has demonstrated comparable or superior efficacy in improving arthritis symptoms, physical function, and remission rates compared to classic DMARDs like methotrexate and some biologics such as adalimumab and etanercept. Clinical trials and meta-analyses have shown tofacitinib monotherapy or in combination can lead to higher ACR20/50/70 response rates and better patient-reported outcomes.
Unlike biologics, which require subcutaneous injections or intravenous infusions, TOFASHINE XR 11MG TABLET is an oral medication, increasing convenience and potentially improving patient adherence. Oral dosing avoids needle-related anxiety and the need for healthcare facility visits for administration.
While sharing some immunosuppressive risks, tofacitinib shows a tolerability profile that can be more favorable for certain patients, with less injection site reactions and comparable rates of serious adverse events to biologics. GI side effects may be less frequent compared to traditional DMARDs like methotrexate.
TOFASHINE XR 11MG TABLET requires regular blood monitoring for blood counts, liver, kidney function, and lipid levels, similar to biologics, but potentially less frequent than complex combination therapies with older DMARDs. This allows targeted safety surveillance while maintaining efficacy.
Tofacitinib’s oral administration can reduce associated healthcare costs like administration fees or facility visits, improving total cost-effectiveness for some patients despite the drug's retail price.
A: No, it helps control symptoms and slow disease progression but is not a cure.
A: It may take several weeks to observe full therapeutic effects.
A: Long-term use requires regular medical supervision due to potential risks.
A: TOFASHINE XR 11MG TABLET contains tofacitinib, which belongs to the group of
medicines called immunosuppressants. It is used to manage inflammatory diseases
such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and
ankylosing spondylitis. It is used together with medicines such as methotrexate
when previous rheumatoid arthritis management was not sufficient or was not well
tolerated.
A: TOFASHINE XR 11MG TABLET can lower the ability of your immune system to fight
infections. Do not start stating this medicine if you have any kind of
infection, a history of infection or are at risk of developing one.
A: TOFASHINE XR 11MG TABLET is not recommended for use by pregnant or
breastfeeding women. If you are a woman of childbearing age, effective birth
control methods must be used during management with this medicine and for at
least 4 weeks after the last dose. Tell your doctor immediately if you become
pregnant while taking the medicine.
A: TOFASHINE XR 11MG TABLET is used to manage polyarticular juvenile idiopathic
arthritis and juvenile psoriatic arthritis, which cause pain and inflammation of
joints in children over 2 years of age. Ask for your doctor?s advice before
giving it to your child.
A: Your doctor might check you regularly for the levels of white blood cells and
red blood cells in your blood while you take TOFASHINE XR 11MG TABLET.
A: If you forgot to take a dose of TOFASHINE XR 11MG TABLET, then do not take
the missed dose between meals. Continue taking your medication as usual until
your next scheduled dose and meal. Do not take a double dose to make up for a
forgotten dose.
A: Patients aged 65 years and older may be at increased risk of infections,
heart attacks and some types of cancer; therefore, it should be used with
caution in patients above the age of 65 years.
TOFASHINE XR 11MG TABLET contains Tofacitinib, a disease-modifying
anti-rheumatic drug (DMARD) belonging to the Janus kinase (JAK) inhibitors
class. It is used to manage moderate to severe inflammatory conditions including
rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and
ulcerative colitis.
TOFASHINE XR 11MG TABLET inhibits Janus kinase enzymes (JAK 1 and JAK 3),
blocking the signaling pathways that lead to inflammation and immune system
overactivation. This results in reduced pain, swelling, and tissue damage in
autoimmune conditions.
Take TOFASHINE XR 11MG TABLET exactly as prescribed by your doctor, usually once
or twice daily. Swallow the tablet whole with water, with or without food. Do
not crush or chew the tablet. Consistent dosing at the same time each day helps
maintain symptom control.
Inform your doctor if you have infections, liver or kidney disease, or a history
of tuberculosis before starting TOFASHINE XR 11MG TABLET. Pregnant or
breastfeeding women should consult their healthcare provider before use.
Avoid live vaccines without medical approval while taking this medication.
Regular monitoring of blood counts and liver function is necessary during
treatment. The common side effects are headache, dizziness, respiratory
infections, increased cholesterol levels, nausea, diarrhea, abdominal pain and
increased risk of serious infections.
TOFASHINE XR 11MG TABLET inhibits Janus kinase enzymes (JAK 1 and JAK 3),
blocking the signaling pathways that lead to inflammation and immune system
overactivation. This results in reduced pain, swelling, and tissue damage in
autoimmune conditions.
TOFASHINE XR 11MG TABLET can be taken with or without food according to medical
sources. It is recommended to take the tablet at the same time each day to
maintain consistent drug levels and o
with food may help reduce potential stomach upset, but it is not mandatory.
It is not safe to crush, chew, break, or split TOFASHINE XR 11MG TABLET. The
tablet should be swallowed whole with water to ensure proper absor
effectiveness.
If you miss a dose, take it as soon as you remember unless it is almost time for
your next scheduled dose. In that case, skip the missed dose and continue with
your regular dosing schedule. Do not take a double dose to make up for the
missed one, as this could increase the risk of side effects.
If you or anyone else accidentally take too much of TOFASHINE XR 11MG TABLET,
consult your doctor immediately or visit the nearby hospital.
!### Pregnancy
ContraindicatedTOFASHINE XR 11MG TABLET is not recommended for use in pregnant women or women
planning to have a baby. If you are a woman of childbearing age, you should use
effective birth control during management and for at least 4 weeks after the
last dose.
!### Breastfeeding
ContraindicatedTOFASHINE XR 11MG TABLET is not recommended for use in breastfeeding women.
!### Driving and Using Machines
Use with CautionTOFASHINE XR 11MG TABLET does not affect your ability to drive or use machines.
!### Kidney
Use with CautionTOFASHINE XR 11MG TABLET should be taken with caution in patients with kidney
disease. The dose will be adjusted by your doctor.
!### Liver
Consult your doctorTOFASHINE XR 11MG TABLET is not recommended in patients with severe liver
problems such as cirrhosis (scarring of the liver). It should be used with
caution in patients having other liver diseases such as hepatitis B or hepatitis
C. Dose will be adjusted by your doctor.
!### Allergy
ContraindicatedDo not take TOFASHINE XR 11MG TABLET if you are allergic to Tofacitinib or any
other ingredients of this medicine.
!### Lungs
Consult your doctorTOFASHINE XR 11MG TABLET is not recommended for use in active tuberculosis. It
should be taken with caution in patients with chronic lung disease or a history
of tuberculosis.
!### Heart Disease
Use with CautionTOFASHINE XR 11MG TABLET should be taken with caution in patients with heart
diseases such as heart attack and high blood pressure.
!### Use In Pediatrics
Consult your doctorThe safety and effectiveness of TOFASHINE XR 11MG TABLET in children below 2
years of age have not been established yet.
!### Use In Geriatrics
Use with CautionTOFASHINE XR 11MG TABLET should be used with caution in patients above the age
of 65 years of age as they may be at increased risk of infections, heart attack
and some types of cancer.
Before taking TOFASHINE XR 11MG TABLET, inform your doctor if you have,
TOFASHINE XR 11MG TABLET is not recommended for use if you have:
Maintain a nutritious, well-balanced diet rich in fruits, vegetables, lean
proteins, and whole grains to support overall health and immune function. Stay
well-hydrated to assist medication metabolism and reduce potential
gastrointestinal side effects.
Engage in low-impact exercises such as walking, swimming, or yoga to improve
joint flexibility, muscle strength, and cardiovascular health without
overstressing inflamed joints.
Because TOFASHINE XR 11MG TABLET suppresses the immune system, practice good
hygiene, avoid close contact with sick individuals, get recommended
vaccinations, and promptly report signs of infection to your healthcare
provider.
Smoking may worsen inflammatory conditions and impair healing, while excessive
alcohol can increase liver stress and gastrointestinal risks. Aim to quit
smoking and limit alcohol intake under medical guidance.
Incorporate relaxation techniques like meditation, deep breathing exercises, or
counselling to reduce stress, which can exacerbate autoimmune symptoms.
Adhere strictly to scheduled blood tests and healthcare appointments to monitor
treatment efficacy and side effects, enabling timely adjustments.
Tuberculosis and Infections:
Patients with active tuberculosis or a history of latent TB should be screened
and managed appropriately before starting TOFASHINE XR 11MG TABLET. The drug
suppresses immune response, increasing susce
vigilance is essential.
Hepatitis
Use caution in patients with a history of hepatitis B or C. Liver function
should be monitored regularly, as TOFASHINE XR 11MG TABLET may affect liver
enzymes and exacerbate underlying liver conditions.
Grapefruit products and St. John’s Wort can affect metabolism and should be
avoided.
| Drug | Tofacitinib |
| Pharmacological Category | Janus Kinase Inhibitors |
| Therapeutic Indication | Inflammatory diseases |
| Dosage Forms | Tablet |
Briefly contrast TOFASHINE XR 11MG TABLET with older DMARDs or biologics
regarding efficacy, side effects, administration ease, or monitoring needs.
TOFASHINE XR 11MG TABLET differs from older traditional DMARDs and biologic
therapies in several important ways that contribute to its unique value:
Tofacitinib has demonstrated comparable or superior efficacy in improving arthritis symptoms, physical function, and remission rates compared to classic DMARDs like methotrexate and some biologics such as adalimumab and etanercept. Clinical trials and meta-analyses have shown tofacitinib monotherapy or in combination can lead to higher ACR20/50/70 response rates and better patient-reported outcomes.
Unlike biologics, which require subcutaneous injections or intravenous infusions, TOFASHINE XR 11MG TABLET is an oral medication, increasing convenience and potentially improving patient adherence. Oral dosing avoids needle-related anxiety and the need for healthcare facility visits for administration.
While sharing some immunosuppressive risks, tofacitinib shows a tolerability profile that can be more favorable for certain patients, with less injection site reactions and comparable rates of serious adverse events to biologics. GI side effects may be less frequent compared to traditional DMARDs like methotrexate.
TOFASHINE XR 11MG TABLET requires regular blood monitoring for blood counts, liver, kidney function, and lipid levels, similar to biologics, but potentially less frequent than complex combination therapies with older DMARDs. This allows targeted safety surveillance while maintaining efficacy.
Tofacitinib’s oral administration can reduce associated healthcare costs like administration fees or facility visits, improving total cost-effectiveness for some patients despite the drug's retail price.
A: No, it helps control symptoms and slow disease progression but is not a cure.
A: It may take several weeks to observe full therapeutic effects.
A: Long-term use requires regular medical supervision due to potential risks.
A: TOFASHINE XR 11MG TABLET contains tofacitinib, which belongs to the group of
medicines called immunosuppressants. It is used to manage inflammatory diseases
such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and
ankylosing spondylitis. It is used together with medicines such as methotrexate
when previous rheumatoid arthritis management was not sufficient or was not well
tolerated.
A: TOFASHINE XR 11MG TABLET can lower the ability of your immune system to fight
infections. Do not start stating this medicine if you have any kind of
infection, a history of infection or are at risk of developing one.
A: TOFASHINE XR 11MG TABLET is not recommended for use by pregnant or
breastfeeding women. If you are a woman of childbearing age, effective birth
control methods must be used during management with this medicine and for at
least 4 weeks after the last dose. Tell your doctor immediately if you become
pregnant while taking the medicine.
A: TOFASHINE XR 11MG TABLET is used to manage polyarticular juvenile idiopathic
arthritis and juvenile psoriatic arthritis, which cause pain and inflammation of
joints in children over 2 years of age. Ask for your doctor?s advice before
giving it to your child.
A: Your doctor might check you regularly for the levels of white blood cells and
red blood cells in your blood while you take TOFASHINE XR 11MG TABLET.
A: If you forgot to take a dose of TOFASHINE XR 11MG TABLET, then do not take
the missed dose between meals. Continue taking your medication as usual until
your next scheduled dose and meal. Do not take a double dose to make up for a
forgotten dose.
A: Patients aged 65 years and older may be at increased risk of infections,
heart attacks and some types of cancer; therefore, it should be used with
caution in patients above the age of 65 years.